Tarsus Pharmaceuticals, Inc. Common Stock TARS
Key Stats
- Today's Range
- $66.34 – $69.66
- 50-Day Range
- $53.89 – $72.50
- 52-Week Range
- $38.51 – $85.25
- Volume
- 741K shs
- Average Volume
- 1.24 million shs
- Market Cap
- $3.05 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.31%
- Days to Cover
- 1.00
About Tarsus Pharmaceuticals, Inc. Common Stock
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
Related Stocks
Compare head-to-head: TARS vs AMGN·TARS vs HALO·TARS vs RGEN·TARS vs IMVT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.